TomoTherapy® in Nasopharyngeal Carcinoma
Nasopharyngeal carcinoma (NPC) is highly prevalent in southeast of Asia, and it is predominantly treated by radiotherapy (RT). Intensity-modulated RT (IMRT) exhibits better dosimetric advantages over two-dimensional RT (2D-RT) or three-dimensional conformal RT (3D-CRT). It has significantly improved the local control rate of NPC and reduced acute and chronic toxicities. Helical TomoTherapy® was an emerging technology that integrates IMRT, image-guided intensity modulated radiotherapy (IGRT) and dose-guided intensity modulated radiotherapy (DGRT). TomoTherapy makes a perfect combination of linear accelerator and helical CT, breaking through many limitations of traditional accelerator. While rotating the irradiation target area, the treatment couch advances axially through the center of the stand, which is used to treat tumors efficiently and accurately. This webinar will focus on the treatment of NPC by TomoTherapy. Firstly, describing the therapeutic mechanism of TomoTherapy, the advantages and limitations of TomoTherapy in the treatment of tumors. This webinar will explain how to implement TomoTherapy in a patient with NPC. Finally, the experience of treating NPC by TomoTherapy in the Sun Yat-sen University Cancer Center, Guangzhou, China will be shared.
Prostate SBRT and the PACE-B trial
Define the current best practice for prostate Stereotactic Body Radiation Therapy (SBRT). Describe the evidence underpinning prostate SBRT practice. Discuss the recently released data from the international PACE-B trial, which randomized patients between standard fractionation radiotherapy and five fraction SBRT.
25 Years of SBRT with CyberKnife
Dr. Anand Mahadevan is the Professor and Chairman of Radiation Oncology and Dr. Jimm Grimm is the Lead CyberKnife Physicist at Geisinger Medical Center.
Glioblastoma re-irradiation with the CyberKnife® System
“Because most patients with glioblastoma (GBM) will recur, mainly within the first radiation therapy (RT) volume, consequently the question of re-RT, post or instead of reoperation, is critical in our daily practice. As there is no standard in this situation of first recurrence, it seems relevant to share and exchange with the neuro-oncologic community about our 10-year experience of GBM re-irradiation, with and without concomitant Bevacizumab, particularly with the CyberKnife system, which holds in our opinion a very unique place.”
New Evidence for Hepatocellular Carcinoma SBRT Treatment with the CyberKnife® System
In this webinar Dr. Song will discuss how survival outcomes for patients with small-sized hepatocellular carcinoma undergoing SBRT are comparable to those following surgical resection and radiofrequency ablation, and how SBRT could be a bridging therapy for hepatocellular carcinoma prior to liver transplantation.
TomoTherapy® based dose-escalated radiation therapy for painful bone metastases using the Scan-Plan-QA-Treat workflow
In this webinar, Drs. Muller and Wijesooriya will discuss their experience with same day simulation, planning, and treatment of painful osseous metastases with dose escalated radiation therapy using the TomoTherapy platform. They will also discuss the prospective trials, and the workflow performed at the University of Virginia. The session will be moderated by Dr. Paul Read.
Tips and Tricks to Treat Central Lung Tumors with the CyberKnife® System
Dr. Nuyttens will share his 15 years of experience in treating lung lesions with the CyberKnife System. He will focus on how effectively central lung tumors can be treated, the challenges faced and how he manages to deliver the most effective dose. Dr. Nuyttens will show actual cases, planning, dose constraints and clinical outcomes.
Total Marrow Irradiation with TomoTherapy®: Redefining the Role of Radiation Therapy in Hematopoietic Cell Transplantation
In this webinar Dr Wong and Dr Liu will provide an overview of the Total Marrow Irradiation technique on TomoTherapy and outline their 15 year experience of treating patients with this approach.
TomoTherapy® for Breast Cancer in a Clinical Practice
In this webinar we will present both clinical and technical aspects of our hypofractationed approach to whole breast, partial breast and breast reirradation using TomoTherapy®. We will describe how we select patient for TomoDirect™ and TomoHelical™ modalities, and will share details of our Phase I/II clinical trial on single fraction ablative preoperative radiation treatment for early-stage breast cancer.
Russian Experience of using Helical TomoTherapy for Total Body Irradiation in Wide Heterogenic Cohort of 262 Pediatric Patients with Hematological Malignancies
Dmitry Rogachev National Research Center in Russia is a leading specialized center in the area of pediatric hematology/oncology and immunology. In this webinar we will share our experience with Helical TomoTherapy for the application of Total Body Irradiation in a wide heterogenic cohort of pediatric patients with hematological malignancies. We have treated 262 pediatric patients since this approach was introduced in our center in 2014.